Skip to main content
Gulf Pharmaceutical Industries logo

Gulf Pharmaceutical Industries — Investor Relations & Filings

Ticker · JULPHAR ISIN · AEG000201018 Abu Dhabi Securities Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2021-12-05 Regulatory Filings
Country AE United Arab Emirates
Listing Abu Dhabi Securities Exchange JULPHAR

About Gulf Pharmaceutical Industries

https://www.Julphar.net

Gulf Pharmaceutical Industries (Julphar) is a prominent pharmaceutical manufacturer and distributor. The company specializes in producing a diverse portfolio of medicines, vaccines, and consumer healthcare products, addressing a broad spectrum of health conditions. Julphar is recognized as one of the largest generic pharmaceutical manufacturers in the Middle East and North Africa, and a leading global producer of insulin. Utilizing internationally accredited, state-of-the-art facilities, it manufactures over one million medicine boxes daily, distributing products to more than 40 countries. The company's operations emphasize high quality and safety standards in its comprehensive manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Julphar signs an exclusive license and production agreement with Quantum Genomics
Regulatory Filings
2021-12-05 English
شركة الخليج للصناعات الدوائية بيانات صحفية عامة
Regulatory Filings Classification · 95% confidence The document is a press release announcing a licensing and manufacturing agreement between Julphar and Quantum Genomics for a new cardiovascular drug. It contains no financial statements, regulatory form references, or detailed financial data. It is a corporate announcement about a strategic partnership and product launch, not a financial report or regulatory filing. The content fits best under a general regulatory announcement or corporate news category rather than a specific financial report or meeting material.
2021-12-05 Arabic
Gulf Pharmaceutical Industries General Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a new exclusive license and production agreement between Julphar and Quantum Genomics. It details the business partnership, geographic rights, and strategic goals but does not contain any financial statements, regulatory filings, or detailed financial data. It is not an earnings release, annual report, or any form of regulatory filing. The content is a corporate announcement about a licensing and production agreement, which fits best under Capital/Financing Update (CAP) as it relates to a strategic business deal impacting the company's product portfolio and market expansion.
2021-12-05 English
شركة الخليج للصناعات الدوائية الافصاح
Notice of Dividend Amount Classification · 90% confidence The document is in Arabic and appears to be a short announcement related to dividends or shareholder information for Gulf Pharmaceutical Industries (Julphar). The text mentions dates around March 2015 and references shareholders and cash dividends. The document length is only 2705 characters, which is quite short and suggests it is not a full financial report. There is no indication of detailed financial statements or comprehensive analysis. The content seems to be an announcement about dividend payments or shareholder distributions rather than a full annual or interim report. Therefore, the most appropriate classification is Notice of Dividend Amount (DIV).
2021-12-04 Arabic
Gulf Pharmaceutical Industries Announcements
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from Gulf Pharmaceutical Industries (Julphar) regarding outstanding cash dividends owed to shareholders before March 1, 2015. It provides instructions for shareholders to claim their unpaid dividends and mentions the transfer of unclaimed dividends to the Securities and Commodities Authority after December 31, 2021. The document does not contain financial statements, detailed financial data, or management discussion. It is primarily an announcement about dividend payments and procedures for shareholders to claim them. Therefore, it fits the category of Notice of Dividend Amount (DIV), as it relates to dividend payment information and shareholder instructions.
2021-12-04 English
شركة الخليج للصناعات الدوائية - تقرير التعافي من الخسائر المتراكمة
Regulatory Filings
2021-11-27 Arabic

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.